AbC-19 rapid antibody test

From WikiProjectMed
Jump to navigation Jump to search

Positive-rate-daily-smoothed (2).png

The AbC-19 rapid antibody test is an immunological test for COVID-19 exposure developed by the UK Rapid Test Consortium and manufactured by Abingdon Health. It uses a lateral flow test to determine whether a person has IgG antibodies to the SARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%.[1]

This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.[1][2]

See also


  1. 1.0 1.1 "AbC-19 | COVID-19 Rapid Antibody Test and Certificate Solution | IgG". Abingdon Health plc. Archived from the original on 9 June 2022. Retrieved 2 August 2021.
  2. Mulchandani, R; Jones, HE; Taylor-Phillips, S; Shute, J; Perry, K; Jamarani, S; Brooks, T; Charlett, A; Hickman, M; Oliver, I; Kaptoge, S; Danesh, J; Di Angelantonio, E; Ades, AE; Wyllie, DH; EDSAB-HOME and COMPARE, Investigators. (11 November 2020). "Accuracy of UK Rapid Test Consortium (UK-RTC) "AbC-19 Rapid Test" for detection of previous SARS-CoV-2 infection in key workers: test accuracy study". BMJ (Clinical Research Ed.). 371: m4262. doi:10.1136/bmj.m4262. PMC 7656121. PMID 33177070.

External links